Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ph80 (1 trial)
ph94b (2 trials)
Anxiety Disorders (Phase 3)
Disease (Phase 3)
Phobia, Social (Phase 3)
Phobic Disorders (Phase 2)
Premenstrual Dysphoric Disorder (Phase 3)
Trials (3 total)
Trial APIs (2 total)